Caredx Inc

Research Caredx Inc (CDNA) on Bullrun: market cap USD 1.51B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCDNA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 1.51B
• Financial periodFY2025
• RevenueUSD 379.81M
• Revenue growth13.8%
• Net income-USD 21.35M

Valuation Snapshot

latest market cap is USD 1.51B.

About Caredx Inc

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.

Frequently asked questions

What is Caredx Inc's market cap?

Caredx Inc's market capitalization is USD 1.51B.

What does Caredx Inc do?

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients;